ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,805Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 2094

$1.14M Total Retail Price of All Prescriptions

Rank: 62 out of 2094

463 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 14,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 672 659 1 4
ZOLPIDEM TARTRATE 654 631 2 14
AMLODIPINE BESYLATE 582 578 3 2
ALENDRONATE SODIUM 488 488 4 30
ATORVASTATIN CALCIUM 464 457 5 5
METOPROLOL SUCCINATE 388 387 6 9
DIOVAN 369 369 7 13
LOVAZA 354 354 8 53
SIMVASTATIN 284 282 9 1
TAMSULOSIN HCL 266 266 10 29
DIOVAN HCT 263 263 11 28
MELOXICAM 243 243 12 49
LOSARTAN POTASSIUM 224 224 13 17
METFORMIN HCL 215 203 14 8
FINASTERIDE 210 210 15 97
FLUTICASONE PROPIONATE 204 204 16 41
LIDODERM 188 188 17 59
AZITHROMYCIN 182 178 18 27
LEVOTHYROXINE SODIUM 181 172 19 3
GLIPIZIDE XL 175 175 20 122
RESTASIS 169 169 21 251
FELODIPINE ER 165 165 22 259
PATANOL 159 159 23 198
DONEPEZIL HCL 158 158 24 20
BETAMETHASONE DIPROPIONATE 151 132 25 202
EXELON 150 150 26 111
DOXAZOSIN MESYLATE 148 148 27 120
SYMBICORT 141 140 28 149
NITROSTAT 140 140 29 314
FUROSEMIDE 138 135 30 6
JANUVIA 127 127 31 35
POTASSIUM CHLORIDE 127 127 31 24
METOPROLOL TARTRATE 120 120 33 10
SERTRALINE HCL 117 117 34 26
METFORMIN HCL ER 115 115 35 67
LEVOCETIRIZINE DIHYDROCHLORIDE 112 112 36 169
TRIAMCINOLONE ACETONIDE 106 106 37 186
CELEBREX 102 101 38 74
LIPITOR 101 97 39 39
EXFORGE 100 100 40 105
SPIRIVA 99 99 41 60
PROAIR HFA 98 98 42 45
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 42 52
NAMENDA 96 96 44 32
MEGESTROL ACETATE 94 94 R 45 174
MOMETASONE FUROATE 91 90 46 229
ADVAIR DISKUS 90 87 47 36
ATELVIA 90 90 47 135
ISOSORBIDE MONONITRATE ER 88 88 49 57
CLOPIDOGREL 87 87 50 22
LISINOPRIL 87 87 50 7
ATENOLOL 87 78 50 21
CIPROFLOXACIN HCL 85 85 53 81
HYDROCHLOROTHIAZIDE 85 85 53 12
LACTULOSE 83 83 55 65
CRESTOR 80 59 56 15
VOLTAREN 76 76 57 109
FEXOFENADINE HCL 74 74 58 191
TRICOR 73 73 59 99
ALLOPURINOL 73 73 59 50
CARVEDILOL 72 72 61 19
MECLIZINE HCL 72 72 61 103
PLAVIX 71 71 63 38
GLIPIZIDE ER 71 71 63 126
NEXIUM 64 59 65 16
CLONIDINE HCL 63 63 66 62
RANITIDINE HCL 61 61 67 80
NIFEDIPINE ER 60 60 68 96
CLOTRIMAZOLE-BETAMETHASONE 56 43 69 91
JANUMET 55 55 70 86
AMOX TR-POTASSIUM CLAVULANATE 53 51 71 107
BONIVA 53 53 71 256
IBUPROFEN 50 50 73 73
TERAZOSIN HCL 50 50 73 240
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.